Menu

Filtros : "Portola" Limpar

Filtros

Refine with date range

  • 1

1 - 2 (2 records)

  • Artigo de periodico

    Edoxaban versus warfarin in Latin American Patients with atrial fibrillation the ENGAGE AF-TIMI 48 trial (2018)

    Corbalan, Ramon; Nicolau, Jose Carlos

    Source: Journal of the american college of cardiology. Unidade: FM

    Subjects: ANTICOAGULANTES, FIBRILAÇÃO ATRIAL, ACIDENTE VASCULAR CEREBRAL, AMÉRICA LATINA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      CORBALAN, Ramon e NICOLAU, Jose Carlos. Edoxaban versus warfarin in Latin American Patients with atrial fibrillation the ENGAGE AF-TIMI 48 trial. Journal of the american college of cardiology, v. 72, n. 13, p. 1466-1475, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.jacc.2018.07.037. Acesso em: 28 jan. 2026.

    • APA

      Corbalan, R., & Nicolau, J. C. (2018). Edoxaban versus warfarin in Latin American Patients with atrial fibrillation the ENGAGE AF-TIMI 48 trial. Journal of the american college of cardiology, 72( 13), 1466-1475. doi:10.1016/j.jacc.2018.07.037

    • NLM

      Corbalan R, Nicolau JC. Edoxaban versus warfarin in Latin American Patients with atrial fibrillation the ENGAGE AF-TIMI 48 trial [Internet]. Journal of the american college of cardiology. 2018 ; 72( 13): 1466-1475.[citado 2026 jan. 28 ] Available from: https://doi.org/10.1016/j.jacc.2018.07.037

    • Vancouver

      Corbalan R, Nicolau JC. Edoxaban versus warfarin in Latin American Patients with atrial fibrillation the ENGAGE AF-TIMI 48 trial [Internet]. Journal of the american college of cardiology. 2018 ; 72( 13): 1466-1475.[citado 2026 jan. 28 ] Available from: https://doi.org/10.1016/j.jacc.2018.07.037

  • Artigo de periodico

    Ticagrelor versus clopidogrel after fibrinolytic therapy in patients with ST-elevation myocardial infarction: rationale and design of the ticagrelor in patients with ST-elevation myocardial infarction treated with thrombolysis (TREAT) trial (2018)

    Berwanger, Otavio; Nicolau, José Carlos

    Source: American heart journal. Unidade: FM

    Subjects: FÁRMACOS (SISTEMA CARDIOVASCULAR), INFARTO DO MIOCÁRDIO, SÍNDROME CORONARIANA AGUDA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      BERWANGER, Otavio e NICOLAU, José Carlos. Ticagrelor versus clopidogrel after fibrinolytic therapy in patients with ST-elevation myocardial infarction: rationale and design of the ticagrelor in patients with ST-elevation myocardial infarction treated with thrombolysis (TREAT) trial. American heart journal, v. 202, p. 89-96, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.ahj.2018.02.017. Acesso em: 28 jan. 2026.

    • APA

      Berwanger, O., & Nicolau, J. C. (2018). Ticagrelor versus clopidogrel after fibrinolytic therapy in patients with ST-elevation myocardial infarction: rationale and design of the ticagrelor in patients with ST-elevation myocardial infarction treated with thrombolysis (TREAT) trial. American heart journal, 202, 89-96. doi:10.1016/j.ahj.2018.02.017

    • NLM

      Berwanger O, Nicolau JC. Ticagrelor versus clopidogrel after fibrinolytic therapy in patients with ST-elevation myocardial infarction: rationale and design of the ticagrelor in patients with ST-elevation myocardial infarction treated with thrombolysis (TREAT) trial [Internet]. American heart journal. 2018 ; 202 89-96.[citado 2026 jan. 28 ] Available from: https://doi.org/10.1016/j.ahj.2018.02.017

    • Vancouver

      Berwanger O, Nicolau JC. Ticagrelor versus clopidogrel after fibrinolytic therapy in patients with ST-elevation myocardial infarction: rationale and design of the ticagrelor in patients with ST-elevation myocardial infarction treated with thrombolysis (TREAT) trial [Internet]. American heart journal. 2018 ; 202 89-96.[citado 2026 jan. 28 ] Available from: https://doi.org/10.1016/j.ahj.2018.02.017
  • 1

1 - 2 (2 records)

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2026